Hospitals and health systems engaged in clinical trials enjoy several benefits — the ability to provide the latest treatment options to patients, the prestige of being a research organization, as well ...
Through this collaboration, GCCL aims to expand strategic partnerships with global CROs and research organizations, strengthen its capability to deliver fully integrated clinical trial solutions ...
The report identifies opportunities in optimizing clinical trial strategies and locations, highlighting key market positions in cholera research. It aids in strategy formulation by providing insights ...
Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...
Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...
Clinical trials are an essential part of medical breakthroughs that help patients, but getting them off the ground and running them is often fraught with challenges. Specifically, qualification, ...
Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
News-Medical.Net on MSN
Analysis reveals why head and neck cancer clinical trials end early
Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results